Latest Regulatory Clearance News

HealthCo Healthcare and Wellness REIT has signed binding agreements for new leases covering its remaining 10 Healthscope hospitals, subject to final approvals. The resolution allows HCW to reinstate quarterly distributions while reducing its largest tenant concentration from 57% to 31%.

Ampol will acquire Evie Networks for $225 million in a debt-funded deal that would more than triple its public charging footprint to approximately 1,425 bays. The transaction offers a faster route into Australia’s expanding EV infrastructure market, but its earnings case depends on regulatory clearance, integration and rising utilisation.

Heartland shareholders have overwhelmingly approved the proposed acquisition of TSB and the creation of TSB Heartland Bank, advancing the transaction toward regulatory completion. The deal still faces outstanding conditions, including a Material Adverse Change test and required approvals.

Clarity Pharmaceuticals is approaching pivotal Phase III readouts for its prostate cancer imaging agent, backed by AUD178.3 million in liquid assets. The radiopharmaceutical developer remains deeply loss-making, but expanded manufacturing capacity and early clinical signals are pulling its commercial ambitions into sharper focus.

Warburg Pincus has lifted its non-binding proposal for Ingenia Communities to $5.25 cash per stapled security, but the revised approach remains conditional on due diligence, board support and financing. Ingenia has not recommended the offer and says no transaction is certain.

Nexsen has proposed a 50:50 joint venture with FlashDx Shenzhen to develop and commercialise an enhanced molecular Group B Streptococcus test, using an existing CE-marked platform as its starting point. The proposed venture could shorten Nexsen’s path into hospital and intrapartum testing across Asia-Pacific, but the term sheet remains non-binding and regulatory work is still ahead.

The Queensland Government has deferred the planned 90-day suspension of The Star Gold Coast’s casino licence until 31 March 2027. The reprieve comes with continued independent oversight and a clear warning that key remediation work remains unfinished.

4DMedical delivered sharp growth in scans, sites and operating revenue as CT:VQ moved into commercial deployment across several global markets. But the company remains loss-making and its auditor issued a qualified opinion over the carrying value of goodwill and other intangible assets.

Helloworld Travel’s acquisition of Crown Currency Exchange can proceed without shareholder approval after ASX confirmed its major transaction rules do not apply. The announcement improves certainty around the deal, but provides no new financial terms or completion details.

Global Lithium’s proposed acquisition of the Nova Operation from IGO has become unconditional after the ACCC waived its notification requirement. Completion is still pending the shutdown and final shipment timetable, with the transaction not yet completed.

Tuas Limited (ASX:TUA) delivered a sharp FY2026 earnings lift as Simba’s mobile and broadband subscriber base expanded, with statutory profit rising 277% to S$26.0 million. The result arrives with the M1 acquisition abandoned, S$364.5 million raised but not yet allocated, and an unresolved Singapore spectrum investigation.

Jindalee Lithium has filed a third amended US registration statement after a second round of SEC comments, keeping its proposed US Elemental Nasdaq listing targeted for the fourth quarter. The transaction still depends on SEC effectiveness, shareholder approval, Nasdaq clearance, funding and other closing conditions.